US 12286406
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted A61KA61K31/40A61K31/4015
Quick answer
US patent 12286406 (Inhibitors of receptor interacting protein kinase I for the treatment of disease) held by The Board of Regents of the University of Texas System expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/40, A61K31/4015, A61K31/415, A61K31/4155